DaVita(US:DVA) ZACKS·2024-07-16 23:05Company Overview - DaVita HealthCare (DVA) has a current PEG ratio of 1.04, which is lower than the Medical - Outpatient and Home Healthcare industry's average PEG ratio of 2.03 [2] - The company's stock has decreased by 3.75% over the past month, underperforming the Medical sector's gain of 0.71% and the S&P 500's gain of 3.82% [9] - As of the latest market close, DaVita HealthCare's stock price was $137.72, reflecting a daily increase of 1.3%, which outperformed the S&P 500's daily gain of 0.64% [10] Financial Performance - The Zacks Consensus Estimates project DaVita HealthCare's earnings for the full year to be $9.62 per share, representing a 13.58% increase from the prior year, with revenue expected to reach $12.74 billion, a 4.97% increase [4] - The upcoming earnings per share (EPS) is projected at $2.47, indicating an 18.75% increase compared to the same quarter of the previous year, with revenue estimated at $3.16 billion, up 5.43% from the prior-year quarter [12] Valuation Metrics - DaVita HealthCare's Forward P/E ratio is 14.13, which is a discount compared to the industry's average Forward P/E of 23.15 [11] Industry Context - The Medical - Outpatient and Home Healthcare industry has a Zacks Industry Rank of 60, placing it in the top 24% of over 250 industries [7] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [3]